This inventor holds 1 USPTO granted patent. Top assignee: Universidad Autónoma De Madrid. Active years: 2015.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2015
Title: Rubén Gil Redondo: Innovator in Pharmaceutical Compounds
Introduction
Rubén Gil Redondo is a notable inventor based in Madrid, Spain. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target specific biological pathways.
Latest Patents
Rubén holds a patent for "Drugs for inhibiting p38 and uses thereof." This invention relates to compounds with a benzoxadiazolyl amine structure that are capable of inhibiting the activation or biological activity of p38 mitogen-activated protein kinase (MAPK). The patent outlines the use of these compounds in treating diseases that can be alleviated by inhibiting p38 MAPK, such as inflammatory diseases or conditions presenting with pain. He has 1 patent to his name.
Career Highlights
Rubén is affiliated with the Universidad Autónoma de Madrid, where he conducts research and develops innovative solutions in the pharmaceutical sector. His work has the potential to impact the treatment of various diseases, showcasing his commitment to advancing medical science.
Collaborations
Rubén collaborates with esteemed colleagues, including Federico Mayor Menéndez and Cristina Murga Montesinos. These partnerships enhance the research environment and foster innovation in their respective fields.
Conclusion
Rubén Gil Redondo is a prominent inventor whose work in pharmaceutical compounds demonstrates the importance of innovation in healthcare. His contributions are paving the way for new treatments that could significantly improve patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile